Weight loss surgery doesn’t just help produce thinner patients, it often produces healthier ones.
Better cholesterol numbers, lower blood pressure readings and a significant reduction — if not elimination — of diabetes and sleep apnea means patients don’t just enjoy a more attractive appearance, but a better quality of life.
As the benefits of weight loss surgery become more apparent, the surgeries are becoming more popular in the U.S. and abroad — creating a higher demand for surgical devices, including gastric bands, intragastric balloons and other non-invasive implements.
Global Industry Analysts, Inc., took a look at the numbers, and has released a comprehensive report predicting sales of bariatric surgical devices for the U.S. and Europe.
The company predicts that by 2015, annual sales of bariatric surgical devices in the U.S. alone will reach $1.9 billion.
This is good news for companies like Allergan, Johnson & Johnson, Cousin Biotech, Ethicon Endo-Surgery and Covidien, to name a few. And of course, it’s good news for their investors, too.
